Early research (Phase 1)Study completedNCT00658892What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Stage IV MelanomaWho this might be right forMelanoma (Skin) Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00104897What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant MelanomaWho this might be right forMelanoma (Skin) Cancer Research UK 25
Large-scale testing (Phase 3)Ended earlyNCT00227617What this trial is testingCombination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more University of California, San Francisco 36
Testing effectiveness (Phase 2)Study completedNCT00021164What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)
Not applicableStudy completedNCT04490564What this trial is testingValidation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/MelanomaWho this might be right forHead and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma Pharmassist Ltd 135
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00349206What this trial is testingSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWho this might be right forMelanomaRecurrent MelanomaStage III Melanoma+1 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Ended earlyNCT00735332What this trial is testingEfficacy Study of TLN-232 in Patients With Recurring Metastatic MelanomaWho this might be right forMelanoma Thallion Pharmaceuticals 49
Not applicableStudy completedNCT06080204What this trial is testingReal-world Study on Adjuvant Octreotide Therapy in pNETsWho this might be right forPancreatic Neuroendocrine Tumor G2 Changhai Hospital 411
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Large-scale testing (Phase 3)Study completedNCT00019682What this trial is testingAldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaWho this might be right forRecurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more National Cancer Institute (NCI) 185
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Testing effectiveness (Phase 2)UnknownNCT02036086What this trial is testingStudy of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node MetastasesWho this might be right forMelanoma Sunnybrook Health Sciences Centre 24
Early research (Phase 1)Study completedNCT00091143What this trial is testingFludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanoma (Skin) Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00060333What this trial is testingAdjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic MelanomaWho this might be right forRecurrent Melanoma Alliance for Clinical Trials in Oncology 20
Early research (Phase 1)Study completedNCT01204476What this trial is testingCixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaWho this might be right forGastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00020358What this trial is testingVaccine Therapy in Treating Patients With MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00438984What this trial is testingTherapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV MelanomaWho this might be right forRecurrent MelanomaStage IV Melanoma Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11
Early research (Phase 1)Study completedNCT00091338What this trial is testingInterleukin-7 and Vaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00390338What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) Pawel Kalinski 22